FolioLanternBeta
ADPTAdaptive Biotechnologies Corp

Susan Bobulsky

Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp, as of Oct 8, 2026Sold $1.4M of stock in the past 12 months: 61% under a disclosed plan and 39% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
23%
share of stake sold at Adaptive Biotechnologies Corp
389K
shares held after the latest filing, Adaptive Biotechnologies Corp
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMar 2026: $544K to cover taxes$544KMarAprMayJun 2026: $396K under a disclosed planJunJul 2026: $157K under a disclosed planJulAug 2026: $75K under a disclosed planAugSep 2026: $32K under a disclosed planSepOct 2026: $193K under a disclosed planOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Adaptive Biotechnologies Corp (ADPT)Chief Commercial Officer, MRDMar 6, 2024Oct 8, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.